Optibiotix Health Plc engages in the research and development of compounds that modify the human microbiome. Its products include SlimBiome, LPLDL, CholBiome, SweetBiotix, LPGOS, and WellBiome. The company was founded by Stephen Patrick O'Hara on June 19, 2006, and is headquartered in Heslington, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company